Liver Hemangioma Might Lead to overestimation of Liver Fibrosis by Fibroscan; A Missed Issue in Two Cases [0.03%]
肝血管瘤可能导致FibroScan检测到的肝纤维化程度过高；两例未被注意的问题
Seyed Hossein Aalaei-Andabili,Leila Mehrnoush,Shima Salimi et al.
Seyed Hossein Aalaei-Andabili et al.
Background: The assessment of liver fibrosis is an important way for prediction of liver disease progression and patient's prognosis. Liver stiffness measurement (LSM) is strongly associated with stage of liver diseases. ...
Case Reports
Hepatitis monthly. 2012 Jun;12(6):408-10. DOI:10.5812/hepatmon.6685 2012
Hepatitis C viral heterogeneity based on core gene and an attempt to design small interfering RNA against strains resistant to interferon in rawalpindi, pakistan [0.03%]
基于核心基因的丙型肝炎病毒异质性及针对巴基斯坦劳瓦尔伯格地区干扰素抗性的株系设计小分子干扰RNA的初步尝试
Sobia Kanwal,Tariq Mahmood
Sobia Kanwal
Background: Global prevalence of Hepatitis C Virus (HCV) infection corresponds to about 130 million HCV positive patients worldwide. The only drug that effectively reduces viral load is interferon-α (IFN-α) and currentl...
The evaluation of hepatitis C virus core antigen in immunized BALB/c mice [0.03%]
免疫BALB/c小鼠模型中丙型肝炎病毒核心抗原的检测与评价
Elham Torbati,Mojgan Bandehpour,Parviz Pakzad et al.
Elham Torbati et al.
Background: Hepatitis infection represents one of the important causes of morbidity and mortality in developing countries, however there is not any effective vaccine against hepatitis C which is one of the significant pro...
Seroprevalence of hepatitis e virus varies considerably among chinese provinces [0.03%]
中国各省戊型肝炎病毒感染率差异显著
Chen Dong,Xing Dai,Jiuhong Liang et al.
Chen Dong et al.
Background: Hepatitis E is a common infection in China, but few studies have been carried out to compare regional and ethnic factors in its prevalence. Ob...
Changing pattern of hepatitis a virus epidemiology in an area of high endemicity [0.03%]
一个高肝炎A病毒区域流行特征的变化模式
Marcello Campagna,Andrea Siddu,Angelo Meloni et al.
Marcello Campagna et al.
Background: Continuous assessment of hepatitis A virus (HAV) seroepidemiology is a useful tool to control the risk of infection. Objectives: ...
Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy [0.03%]
低剂量利巴韦林治疗输血传播病毒感染的β-地中海贫血患者的Ⅰ期研究
Seyed Vahid Tabatabaei,Seyed Moayed Alavian,Maryam Keshvari et al.
Seyed Vahid Tabatabaei et al.
Background: Treatment guidelines contraindicate ribavirin for treatment of hepatitis C virus (HCV) infection in thalassemia major patients. Nevertheless, the current evidence suggests that ribavirin might be tolerated by ...
Cristin Constantin Vere,Costin Teodor Streba,Liliana Streba et al.
Cristin Constantin Vere et al.
Treatment of patients with HCV related cirrhosis: many rewards with very few risks [0.03%]
治疗丙型肝炎相关失代偿期肝硬化患者：利大于弊
Roberta D&#x;Ambrosio,Alessio Aghemo
Roberta D&#x;Ambrosio
Antiviral treatment of chronic hepatitis C virus (HCV) is aimed at the persistent eradication of the virus, the so-called sustained virological response (SVR), with the aim ultimately being to prevent the development of liver-related compli...
Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro [0.03%]
体外药物耐药性聚合酶突变对HBeAg阳性及HBeAg阴性乙肝病毒株复制的影响
Frank Tacke,Elham Shirvani-Dastgerdi
Frank Tacke